The 3rd International Electronic Conference on Brain Sciences
Part of the International Electronic Conference on Brain Sciences series
1–15 Oct 2022
Clinical neuroscience, Cognitive Neuroscience, Systems Neuroscience, Molecular and cellular neuroscience, Developmental neuroscience, Behavioral Neuroscience and Environmental Neuroscience
- Go to the Sessions
-
- 1. Behavioral Neuroscience
- 2. Molecular and Cellular Neuroscience
- 3. Developmental Neuroscience
- 4. Neuropsychology
- 5. Systems Neuroscience
- 6. Sensory and Motor Neuroscience
- 7. Computational Neuroscience and Neuroinformatics
- 8. Neurorehabilitation
- 9. Neurotechnology and Neuroimaging
- 10. Poster Session
- Event Details
-
- Winners Announcement ------ Best Paper Award, Best Poster Award and Best Speaker Award
- List of Accepted Submissions
- IECBS | Live Session
- Live Session Program
- Live Session Recording
- Event Speakers
- Welcome from the Chair
- Event Chair
- Session Chairs
- Sessions
- Instructions for Authors
- Special Issue
- Event Awards
- Conference Secretariat
- Sponsors and Partners
- Events in series IECBS
IECBS 2022 is closed. Thanks for your participation.
You could download the certification at your sciforum account.
See you in next edition.
Winners Announcement ------ Best Paper Award, Best Poster Award and Best Speaker Award
We are pleased to announce the Best Paper, Best Poster, and Best Speaker Award winners.
The Best Paper Award has been granted to:
Matteo Rizzato, Michele Antonelli, Sharon D'Anzi, Cinzia Di Dio, Antonella Marchetti, Davide Donelli *
The Best Poster Award has been granted to:
Pharmacological Modulation of HIF-1α in The Cerebral Cort1ex of Rats after Chronic Prenatal Hypoxia
The Best Speaker Award has been granted to:
The role of non-coding RNA circSMARCA5 in glioblastoma multiforme
Davide Barbagallo
Each Contribution will receive 300 CHF, and the winners will receive a certificate and an opportunity to publish a paper in Brain Sciences with a voucher of 1000 CHF before 1 June 2023.
List of accepted submissions (24)
Id | Title | Authors | Poster PDF | ||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
sciforum-060525 | The impact of face masks used for COVID-19 prevention on emotion recognition in facial expressions: an experimental study | , , , , , |
Show Abstract |
||||||||||||||||||||||||||||||||||||||
This study aimed to evaluate the impact of face masks used for COVID-19 prevention on emotion recognition in facial expressions. Seventy-two (72) adult participants (48 females, 24 males) attempted to correctly identify different emotions displayed by a female and a male actor’s facial expressions. Simulated emotions included neutrality, happiness, surprise, disgust, sadness, fear, and anger at two levels of intensity, with or without wearing a surgical mask. Accuracy rates of facial expression recognition and response times were collected. The GLM analysis for accuracy revealed a main effect of emotions (F(5,350)=57.47, P<.001) and face masks (without>with) (F(1,70)=338.95, P<.001), as well as a three-way interaction between emotions, masks, and actors (F(5,350)=9.69, P<.001). Disgust was the least recognized emotion, followed by sadness, while happiness, anger and surprise were the easiest to identify. The analysis of response times suggested that, when partially covered by a mask, facial expressions can be more ambiguous and difficult to read, and a larger amount of time was required to provide a response. In line with results on accuracy, sadness was generally the most difficult emotion to identify. Male and female participants had similar response times. Globally, these results show that wearing masks can significantly reduce the ability to detect emotions in facial expressions. However, when emotions are expressed at higher intensity levels, this effect may be mitigated. |
|||||||||||||||||||||||||||||||||||||||||
sciforum-062899 | Association of COVID-19 and down syndrome; a systematic review | , , | N/A |
Show Abstract |
|||||||||||||||||||||||||||||||||||||
Background: Covid-19 has become a global concern. Many risk factors have been identified. Down syndrome which is 21 trisomy affects the mental and physical health of the patient. The syndrome has many neurological complications, which include structural changes, mental retardation, young-onset Alzheimer's disease, strokes and basal ganglia damage. Very less data is available regarding the association of COVID with down syndrome. Objective: The objective of this systemic review is to focus on different evidence available related to the association of COVOD with down syndrome. Method: PubMed/Medline, Science Direct, Web of Science, and Scopus databases were used to find the research done related to the association of COVID with down syndrome up to 2022. Results: this systemic review includes 8 studies. All studies showed that Down syndrome is associated with severe COVID and can lead to hospitalization. Discussion: Down syndrome leads to severe immune dysregulation. Scientists are investigating the exact mechanism behind the dysregulation of the immune system caused by trisomy 21 or down syndrome but still, the research on it is going on. In DS, chromosome 21 activates multiple genes which cause hyperactivity of the immune system. Chromosome 21 encodes the following immune regulators: interferon (IFN) receptors, (IL)-10, IL-22, and IL-26. Immune and non-immune cells are sensitive to IFN and many studies report that in the absence of any infection there is still hyperactivity of T cells due to TFN in DS patients. IFN response which is involved in the antiviral response is vigorous in DS patient and lead to cytokine storm. Recent studies showed that COVID infections are driven by an exacerbated immune response to the virus, leading to cytokine storm, acute respiratory distress syndrome, thromboembolic processes, and multi-organ failure. Conclusion: Patients with COVID and down syndrome are more vulnerable and should be prioritized for vaccination. |
|||||||||||||||||||||||||||||||||||||||||
sciforum-063353 | The influence of the body processing in the development of empathy in early adolescence: a preliminary study | , , , , |
Show Abstract |
||||||||||||||||||||||||||||||||||||||
Mental representations in various bodily formats (e.g., somatosensory, interoceptive, motoric) have been suggested to play a pivotal role in social cognition. However, data on children and adolescents are lacking. This study aims to investigate whether individual differences in the sensing of the internal body state, in terms of interoceptive accuracy (IAcc) and sensibility (IS), and in the action-oriented (i.e., body schema) and nonaction-oriented (i.e., visuo-spatial body map) body representations (BR) influence a core component of the social cognition, namely empathy, during the early adolescence. Thirty healthy teens (mean age 13.2 yrs) completed an empathy questionnaire, a heartbeat tracking task probing IAcc, an IS questionnaire, including a visceral and a somatosensorial factor, and a computerized battery consisting of action-oriented and nonaction-oriented BR tasks. The correlational analysis showed that as IAcc increased, the empathy levels decreased, while as IS increased, the empathy levels increased, especially when the visceral factor was taken into account. No association was found between action/nonaction-oriented BR and empathy. These preliminary results suggest that teens with a higher sensibility towards visceral body changes also show a higher tendency to feel and understand another's emotional state. In contrast, teens with higher IAcc for cardiac signals show a lower empathy level, possibly due to a more stable body self-representation that prevents the self-other overlap necessary in some form of empathy. As a corollary finding, the opposed relation between these interoceptive dimensions and empathy confirms that IS and IA are two distinct constructs that can impact cognitive and affective abilities differently. |
|||||||||||||||||||||||||||||||||||||||||
sciforum-063417 | Immigration and Logotherapy: Addressing and Mental Health Problems among Muslim Immigrants in Europe. | , |
Show Abstract |
||||||||||||||||||||||||||||||||||||||
Depression, stress, anxiety disorders, and PTSD are some of the mental health problems which are prevalent among immigrant populations despite being underdiagnosed. Stigma, difficulties in adapting, cultural barriers, and reduced access to mental health support can seriously hamper their ability to build resilience and recover. Other limitations include assuming that therapies can be universally applied, the lack of sufficient evidence on mental health issues of this population, and the use of therapeutic models developed on Caucasian populations. Here, professional guidance to find the meaning of life through interventions such as logotherapy could help them in this process. The present work systematically reviewed studies investigating the effectiveness of logotherapy in diverse populations and its relevance to a Muslim immigrant population in Europe. Following PRISMA guidelines and the keywords 'logotherapy, mental health problems, immigrant, and treatment', the search identified 16 relevant studies conducted since 2005. The studies revealed that logotherapy could be implemented through paradoxical intention, dereflection, Socratic dialogue, and attitude modification. All these techniques had the potential to help the client to realize long-term relief for underlying stressors associated with migration and settling in a new location. Though data on logotherapy is still scarce, it is evident that it deserves more research so that a structured, evidence-based, and effective therapy for Muslim immigrants in Europe can be developed and tested. In this regard, we propose that the four logotherapy techniques have huge potential in helping psychiatrists develop an effective therapy for mental health problems among these immigrant populations confronting adversity. |
|||||||||||||||||||||||||||||||||||||||||
sciforum-063418 | Obesity, impaired glucose metabolism and hepatic histopathological damage in 3xTg-AD mice at different stages of disease compared to mice with normal aging | , |
Show Abstract |
||||||||||||||||||||||||||||||||||||||
The crosstalk between obesity, diabetes, steatohepatitis, and dementia creates a controversial scenario also when studied using animal models. In the present work, this crosstalk was investigated in male and female 3xTg-AD mice for Alzheimer’s disease (AD) at different ages/stages and compared to sex- and age-matched counterparts with normal aging. The relevance of the genetic background and classical intrinsic factors (AD genotype and sex) were determined using a retrospective analysis of population data and an experimental design. Age/stage of disease was considered a source of stochastic and non-stochastic factors. Data from two different colonies of 3xTg-AD mice with distinct genetic backgrounds were analyzed to verify the functional interplay between the studied factors. Data from asymptomatic/prodromal to early/advanced stages of the disease were screened. Then, all factors' relationships were studied in an experimental design using the same set of animals. The population data unveiled that the genetic background and sex effects were confirmed with regards to the variable body weight, with changes during the disease development and progress. Besides, sexual dimorphism was found as an important factor in glucose metabolism. Statistically significant differences in glucose tolerance and behavioral assessment (exploration, anxiety, and cognition in a two-days open-field paradigm) were found when all the factors were analyzed. In summary, the present study shows that all the studied factors should always be considered when assessing the outcome of the research interventions in the field because they have a distinct functional interplay through the process of normal and AD-pathological aging and from a gender perspective. |
IECBS | Live Session
Welcome! You are invited to join in IECBS 2022 Live Session.
It is totally free to attend. You only need to register for the live session you want to join in. Registrations with academic institutional email addresses will be prioritized. After registering, you will receive a confirmation email about joining the webinar. The number of participants to the live session is limited but the recording will be made available on Sciforum shortly afterwards.
The live streaming platform we are using is Zoom. During each session, the participants will have the possibility to ask questions during a Q&A session. Detailed information about the topics and dates will be shared soon.
The session is on 10 October 2022 at 3:00pm CEST (BASEL TIME). You register by clicking this button:
For our invited speakers, IECBS 2022 would like to grant an award for our best speaker presented in the live session of the conference. The winner will receive a certificate, 300 CHF and an opportunity to publish a paper in Brain Sciences with a voucher of 1000 CHF before 1 June 2023.
Live Session Program
IECBS 2022 | live session chaired by Prof. Dr. Stephen D. Meriney on 10 October 2022 at 3:00pm CEST
3:00-3:05 Chair Introduction
3:05-3:35 Dr. Davide Barbagallo: The role of non-coding RNA circSMARCA5 in glioblastoma multiforme
3:35-4:05 Dr. Prachi Srivastava: Meta-analysis of RNA-Seq Data Identifies Potent Biomarker for Intellectual Disability Disorder (IDD)
4:05-4:35 Dr. Dua Ahmed Ali: Association of COVID-19 and Down Syndrome
4:35-4:50 Discussion and Q&A
Live Session Recording
Invited Speakers
Assistant Professor (tenure track) at University of Catania, Department of Biomedical and Biotechnological Sciences
Title of the talk: The role of non-coding RNA circSMARCA5 in glioblastoma multiforme
Davide Barbagallo is a tenure-track Assistant Professor at University of Catania, Italy. Davide did his PhD studies in the lab of Professor Michele Purrello, University of Catania, working on the involvement of the apoptotic machinery in the etiology of diabetes mellitus. Following this, in 2009, he started his Postdoc activity in the same lab where he focused on the study of non-coding RNA, especially microRNAs, and their involvement in diabetes mellitus and cancer. In 2010, his PhD thesis was awarded as the best in the field of complex biological systems from the Gioenian Academy. In 2017 he was awarded the Umberto Veronesi Foundation Post-doctoral fellowship and he joined Professor Jørgen Kjems’ non-coding RNA lab, University of Aarhus, Denmark, where he spent 6 months to improve his knowledge on circular RNAs (circRNAs), another class of (mostly) non-coding RNAs, recently discovered as critical regulators of gene expression. During his stay at the non-coding RNA lab, under the tutorship of Dr. Thomas Birkballe Hansen, Davide cloned the sequence of circSMARCA5 into an expression vector and showed the tumor suppressive function and mechanism of action of this circRNA in glioblastoma multiforme. In 2018, Davide got back to University of Catania, at the Department of Biomedical and Biotechnological Sciences where he has continued his work on circRNAs.
Amity Institue of Biotechnology - Amity University, Uttar Pradesh, Lucknow
Title of the talk: Meta-analysis of RNA-Seq Data Identifies Potent Biomarker for Intellectual Disability Disorder (IDD)
Dr. Prachi Srivastava is Senior Faculty at Amity Institue of Biotechnology - Amity University, Uttar Pradesh, Lucknow. She has made significant research contributions in bioinformatics, Occuloinformatics and Neuroinformatics are her key areas of interest. She has presented many of papers in national and international forums & conferences; many invited talks and key note speaker is recognized by journals of high repute. She has more than seventy-five publications and more than a hundred of her abstracts to her credit. She has actively organized many national and international conferences, seminars, training programs, and FDP. She has also chaired many national and international sessions of conferences as well as delivered talks and guest lectures at different national and international scientific forums and academic platforms She was won many awards during her academic and scientific journey including STOX Gold Medal, AEB Best paper presentation award, BRPM award, Faculty appreciation award From DOEACC, and best Amity Lucknow Campus best Academic award ‘Parashakti’.Recently, she was awarded the coveted international JNS (Japan Neuroscience) Award and also conferred with 'Fellow of the National Academy of Environmental Biology (FNAEB)'Moreover, as recent as 2020 -2021 , she was granted three copyrights 'GeVan and 'Tulna'and Pest I. Three of her books and more than ten of her book chapters are published under reputed publishers .In addition, she is also a member of many international societies & advisory boards, reviewer, and editorial team for numerous national and international journals of high repute. Her students mirror her passion and more than eighteen of her students have won different awards at the national and international level, under her mentorship. Furthermore, Eleven of her supervised students have been awarded a doctorate and are successfully working in their domains. At present, she is mentoring more than three students for their doctoral research degrees.
Title of the talk: Association of COVID-19 and Down Syndrome
Dr. Dua Ahmed Ali is a final year medical student at Dow medical college. She is interested in persuing research in the field of internal medicine. She is aspiring to become a gastroenterologist. she has published research articles in the field of psychology and internal medicine in national and international journals. Her recently research related to association of schizophrenia with CKD was selected at world psychiatry association congress. 4 of the researches were presented at Boston congress of public health and published at Harvard public of health review. The research related to association between vitamin d and hepatitis B was selected at HBV meeting. She is a PAK USA alumni and member of several different NGOs like PWA and SOCH.
Welcome from the Chair
You are cordially invited to participate in the 3rd International Electronic Conference on Brain Sciences (IECBS2022). This event aims to bring together researchers working in the field of neuroscience, to present and discuss their recent contributions, without the need for travel.
The field of neuroscience is one of the most important frontiers in biomedical studies, as many of the details that control brain function are still not well understood. This makes the study of the nervous system very exciting and fast moving. This conference will address a variety of research topics which reflect some of the current areas of focus. Topics of the conference will be organized around the following 10 sessions:
- Behavioral neuroscience
- Molecular and cellular neuroscience
- Developmental neuroscience
- Neuropsychology
- Systems neuroscience
- Sensory and motor neuroscience
- Computational neuroscience and neuroinformatics
- Neurorehabilitation
- Neurotechnology and neuroimaging
- Poster session
All accepted file submissions will be published in the Biology and Life Sciences Forum, the proceedings of the conference, and authors are invited to elaborate their abstracts into full manuscripts that will be considered for publication in Brain Sciences, with a 20% discount on the APC. Brain Sciences is an open access MDPI journal in the field of neuroscience. The journal is indexed in the Sciences Citation Indexing Expanded (SCIE, Impact Factor: 3.333), Scopus, and other databases. Citations are available in PubMed; full text archived in PubMed Central (PMC). Please visit the following website for more information.
Important Dates
• Abstract Submission: 1 July 2022 25 July 2022
• Notification of Acceptance: 22 July 2022 5 August 2022
• Submission of Full files: 19 August 2022 5 September 2022
• Conference Date: 1–15 October 2022
You are welcome both to upload and present your work and to attend the conference completely free of charge.
Please do not hesitate to contact us if you have questions.
Best wishes,
Prof. Dr. Stephen D. Meriney
Chair of the 3rd International Electronic Conference on Brain Sciences
Event Chair
Department of Neuroscience, University of Pittsburgh, Pittsburgh, USA
Stephen D. Meriney completed his PhD in Physiology/Neuroscience at the University of Connecticut with Dr. Guillermo Pilar in 1986, where he studied the parasympathetic control of intrinsic eye muscles. He then moved to the Jerry Lewis Neuromuscular Research Centre at the University of California, Los Angeles (UCLA) as a postdoctoral fellow, and then became an assistant research physiologist there, with Dr. Alan Grinnell, and studied voltage-gated calcium channels and synaptic mechanisms at the neuromuscular junction. He has been at the University of Pittsburgh since 1993, where he is currently a Professor, and Chair of the Department of Neuroscience, with a secondary appointment in the Department of Psychiatry at the University of Pittsburgh Medical Center. He is currently Editor-in-Chief of the journal Brain Sciences.
Event Committee
Department of Neurobiology and Anatomy, Drexel University College of Medicine, Philadelphia, USA
Dr. Toyooka is an assistant professor in the Department of Neurobiology & Anatomy at Drexel University College of Medicine. He did postdoctoral fellowships at the University of California San Diego and the University of California San Francisco. He also served on the faculty at Osaka City University School of Medicine in Japan. He was appointed to the faculty in the Department of Neurobiology & Anatomy at the College of Medicine in 2013.
Department of Biomedical Sciences and Biotechnologies (Biometec), The University of Catania, Catania, Italy,
Research Unit of Rare Diseases and Neurodevelopmental Disorders, The Oasi Research Institute-IRCCS, Troina, Italy
Prof. Corrado Romano is a graduate in Medicine and Surgery from the Catholic University of Sacred Heart School of Medicine and Surgery, Italy. His scientific background is also focused on pediatrics and Medical genetics. He has been working in the Oasi Research Institute-IRCCS at Troina for many years up to october 2021. In 2003, he became the Head of the Unit of Pediatrics and Medical Genetics, and in 2017, the Head of the Laboratory of Medical Genetics and of the Department of Laboratories at the same Institute. He was elected President of the local IRB for the term 2019–2022 on 22 July 2019. His scientific work is focused on Medical Genetics of Neurodevelopmental Disorders, contributing to the delineation of new genetic syndromes linked to neurodevelopmental disorders, such as 17q21.31 deletion, 15ql3.3 deletion, 1q21.1 deletion, 2q23.1 deletion, 16p12.1 deletion, 7ql1.23 duplication, and the Haploinsufficiency of ADNP, CHD8, DYRK1A, NAA15, DDX3X, ACTL6B, ADGRB3, FBX011, CSDE1, TANC2 and HnRNP genes. He has published more than 240 articles in international peer-reviewed scientific journals, with more than 9000 citations, as well as contributed as an Associate Editor for the Journals Frontiers in Pediatrics, Frontiers in Public Health, Frontiers In Genetics and Brain Sciences. He has also been invited as Chairman and Speaker in several national and international meetings. Since 2005, he has held, in Troina, with an International Scientific Committee, an International Meeting on the Genetics of Neurodevelopmental Disorders, which has reached its 15th Edition. Since november 2021, he has been appointed by the University of Catania as Associate Professor of Medical Genetics within the Section of Medical Biochemistry at the Department of Biomedical and Biotechnological Sciences. Under a shared platform of scientific collaboration he’s Head of the Research Unit of Rare Diseases and Neurodevelopmental Disorders at the Oasi Research Institute-IRCCS in Troina.
Department of Psychiatry, Weill Cornell Medicine, White Plains, USA
I am a psychiatrist on faculty at Weill Cornell Medicine and am the Psychiatric Diseases Section Editor for Brain Sciences. I see patients admitted to New York-Presbyterian Hospital, teach students (medical, psychiatry, geriatric psychiatry, psychology, nursing, and nurse practitioner), conduct research projects, and support other research activities as a journal reviewer and editor. My background: After graduating from Caltech with a degree in Engineering and Applied Science I worked for IBM developing computer graphics methods and leading a natural language project, before shifting to the study of the human body and mind (medical degree from Lund University). During my NIH-funded research fellowship in geriatric mood disorders and neuroimaging (mentor George Alexopoulos), I focused on research methodology. My most recent work aims to improve fMRI methods and the productivity of our scientific endeavors.
School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, USA
Hasan Ayaz, Ph.D. is Provost Solutions Fellow and Associate Professor at the School of Biomedical Engineering, Science and Health Systems with affiliations at the Department of Psychological and Brain Sciences, and Solutions Institute at Drexel University, Adjunct Professor at the University of Pennsylvania, and Associate Fellow at the Children's Hospital of Philadelphia; and a core member of the Cognitive Neuroengineering and Quantitative Experimental Research Collaborative. He directs the Drexel Neuroergonomics Research Core, focusing on understanding human brain functioning using mobile neuroimaging in realistic and real-world environments, across the lifespan and from healthy (typical to specialized groups) to diverse clinical conditions (mental health to neurological). His research aims to design, develop, and utilize (i.e., to measure->elucidate->enable) next generation brain imaging for neuroergonomic applications over a broad spectrum from aerospace to healthcare. He organized and chaired multiple international conferences on this as well as research topics dedicated to mobile neurotechnology and studying brain at work and everyday life.
Section on Gene Structure and Disease, Laboratory of Cell and Molecular Biology, National Institute of Diabetes, Digestive and Kidney Diseases, Bethesda, USA
Dr. Daman Kumari is a Staff Scientist in the Laboratory of Cell and Molecular Biology at the National Institutes of Health. She received her PhD in Life Sciences from the Jawaharlal Nehru University in New Delhi, India. Dr. Kumari studies the mechanism of repeat expansion mediated silencing of the FMR1 gene in fragile X syndrome. Dr. Kumari serves on the editorial board of Brain Sciences.
Research Institute, Casa Colina Hospital and Centers for Healthcare, Pomona, USA
I have been working as a clinical scientist in the neurorehabilitation field for the past 15 years. I focus my research on brain-injured patients with Disorders of Consciousness (DOC) and, more particularly, on the assessment of their brain activity and cognitive functions using behavioral, electrophysiological and neuroimaging techniques. I have published more than 100 articles (H-index: 53) in international peer reviewed journals such as Neurology, Annals of Neurology, Nature Reviews Neurology and Lancet. I serve as the chair of the Special Interest Group on DOC for the International Brain Injury Association and I am actively involved in the Curing Coma Campaign. I currently work as assistant director at the Research Institute of Casa Colina Hospital and Centers for Healthcare (Pomona, CA).
Associate Professor in Clinical Psychology (Clinical Neuropsychology) at the eCampus University of Novedrate (Como, Italy). Director of the Clinical Psychology Service, Saint George Foundation, Cavallermaggiore (Cuneo, Italy). Past: 2008-2012: Chair of the Forum of Young Researchers (FYRE) of the World Federation of Neurology - Research Group on Aphasia, Dementia and Cognitive Disorders (WFN-RGADCD). EDUCATION 2009-2012 Four-year certified clinical training in Psychotherapy (Turin, Italy). 2005-2008 Ph.D. in Cognitive Science – The University and the Polytechnic of Turin, Italy, with a Ph.D. dissertation about the cognitive assessment of patients affected by neuro- degenerative conditions. 2007-2008 M.Sc. in Human Cognitive Neuropsychology - The University of Edinburgh, Scotland (UK). 2003 Graduate in Psychology, The University of Turin. Graduated with honours. FIELD OF RESEARCH (KEYWORDS) Neuropsychology: Neuropsychological rehabilitation; cognitive functions; experimental and clinical studies of traumatic brain injuries and neurodegenerative diseases; neuropsychological assessment. Psychiatry and Clinical Psychology: Design and implementation of multi-centric clinical trials to investigate patients’ adherence to therapeutic interventions; evaluation of clinical interventions; Depression; CBT; EMDR. Foundations of cognitive sciences: Mind and brain correlations; theory of mind; mental states. I have authored more than 40 scientific publications on International peer-reviewed scientific journals (please see details here: https://orcid.org/0000-0002-4784-0803)
School of Engineering, Computing and Mathematics, Oxford Brookes University, Oxford, UK
Dr Tjeerd V. olde Scheper works in the School of Engineering, Computing, and Mathematics at Oxford Brookes University (UK). His research is in Dynamic Systems and Neurocomputation. He is particularly interested in the manner in which Biological Systems resolve problems in dynamics, and in mechanisms to apply those concepts to Engineering, Health, and Medical problems. He developed and patented a control method called Rate Control of Chaos, which limits the nonlinear dynamics of complex control problems into stable control domains with wide ranges of application in control of Wind turbines, Bioreactors and Engine control. He also created a method for nonlinear data representation Criticality Analysis that allows improved machine learning performance and the analysis of dynamic biological data. He also developed the concept of Dynamic Hebbian Learning that allows STDP to emerge from local dynamic interactions within a dendrite.
Dr. Min Zhou is an Associate Professor of Neuroscience at the Ohio State University Wexner Medical Center. Dr. Zhou’s NIH-funded research focuses on the physiology and pathophysiology of astrocytes, a glial subtype that are linked through conduit proteins, gap junctions, into a syncytium. The syncytial coupling has been indicated in his recent study to confer an isopotentiality to astrocytes network, by which astrocytes operate as a functional system in brain homeostasis. In ongoing studies, he is investigating 1) the anatomical basis, gap junction, ion channel mechanisms and biophysical rationale underlying this newly appreciated glial mechanism; 2) how neuronal signaling regulates the functional states of astrocyte syncytium, and that in turn, subserves brain homeostasis and synaptic transmission; and 3) how disruption of an astrocyte syncytium, at both of the structural and functional levels, is etiologically associated with neurological disorders, such as stroke, epilepsy, and depression. Dr. Zhou is an Associate Editor of Frontiers in Physiology, serves for the editorial boards of Brain Sciences Neuroglia Section, Neural Regeneration Research and others.
Faculty of Medicine, University of Lisbon, Lisbon, Portugal,
Instituto de Medicina Molecular João Lobo Antunes, Lisbon, Portugal
Dr. Susana Pinto is a consultant in Physical Medicine and Rehabilitation in Akademiska sjukhuset, Uppsala, Sweden and a clinical researcher at Instituto de Medicina Molecular João Lobo Antunes, Lisbon, Portugal as well as an Invited Associate Professor at Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. Interested in neuro rehabilitation and respiratory rehabilitation, neurophysiology, phenotype-genotype, sensors, telemonitoring, new technologies.
Department of Psychology, University of Milano-Bicocca, 20126 Milan, Italy
Giuseppe Vallar, MD, is Professor Emeritus of Psychobiology and Physiological Psychology in the Department of Psychology of the University of Milano-Bicocca, Milan, Italy. Neuropsychology, with studies investigating disorders of human cognition caused by brain damage, is the main research interest. Topics include disorders of spatial cognition (specifically, the syndrome of unilateral spatial neglect, in its clinical manifestations, neurofunctional architecture, modulation by sensory signals in the short-term and for long-term rehabilitation), the neurofunctional architecture of verbal short-term memory, the effects of electrical and magnetic stimulations on cognitive processes, apraxia, the methodological foundation and the history of neuropsychology. He is the author of over 250 publications and the co-editor of several books on spatial cognition, short-term memory, and, in 2018, of ”The parietal lobe”, a volume of the Handbook of Clinical Neurology series.
Session Chairs
Prof. Dr. Pierluigi Zoccolotti
Department of Psychology, Sapienza University of Rome, Rome, Italy
Session 4. Neuropsychology
Pierluigi Zoccolotti is currently full professor of General Psychology in the Department of Psychology of the Sapienza University of Rome. He teaches Psychology of Learning Disabilities in the “Cognitive Neurosciences and Psychological Rehabilitation” international graduate program, participates in the PhD program in “Behavioral Neurosciences” and in the post-graduate School of Specialization in “Neuropsychology” and coordinates the post-graduate master program in “Disturbances of learning and cognitive development”. Across the years, research interests spanned various areas of cognitive psychology and experimental and clinical neuropsychology, including studies on human lateralization, visuo-spatial neglect and attentional disturbances in patients with vascular etiology, traumatic brain lesions or Alzheimer disease. He also worked on the development of cognitive rehabilitation programs for spatial neglect and hemianopia. Since the late 90’s his research has focused on developmental reading and spelling deficits. This theme was examined in studies ranging from perception to eye movements and psycholinguistic analysis. As part of this interest, he also developed various test materials and rehabilitation trainings.
Prof. Dr. Konstantin V. Slavin
Department of Neurosurgery, University of Illinois at Chicago, Chicago, USA
Session 5. Systems Neuroscience
Konstantin Slavin, MD, FAANS is Professor, Chief of Section and Fellowship Director for Stereotactic and Functional Neurosurgery in the Department of Neurosurgery at the University of Illinois at Chicago (UIC). Dr. Slavin graduated from medical school in Baku, Azerbaijan in the Soviet Union and completed his neurosurgery residency in Moscow. He then completed his second neurosurgery residency at UIC and a fellowship in functional and stereotactic neurosurgery at Oregon Health Sciences University in Portland, OR. Dr. Slavin is the Past President of the American Society for Stereotactic and Functional Neurosurgery and current Vice-President of the World Society for Stereotactic and Functional Neurosurgery. He is also the President-Elect of the International Neuromodulation Society (INS) and past Secretary of the North American Neuromodulation Society (NANS). For many years, he was an Executive Committee member of the Joint Section on Pain of the American Association of Neurological Surgeons and Congress of Neurological Surgeons. Among many honors and awards he is particularly proud to be an Honorary Professor of the Burdenko Neurosurgical Institute in Moscow. Dr. Slavin is published in many books and peer-reviewed journals and is an associate editor or editorial board member for a number of publications, including Neuromodulation, Neurosurgery, Brain Sciences, Stereotactic and Functional Neurosurgery, Acta Neurochirurgica and others; he is the current editor-in-chief of Progress in Neurological Surgery. His first book on Peripheral Nerve Stimulation was published in 2011; another book, co-edited with Sam Eljamel on Neurostimulation: Practice and Principles, came out in 2013; the third one, Stimulation of Peripheral Nervous System: The Neuromodulation Frontier was released in 2015. The most recent book on Neuromodulation for Facial Pain came out in 2021.
Prof. Dr. Zubair Ahmed
Neuroscience and Ophthalmology, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
Session 8. Neurorehabilitation
Zubair Ahmed completed a PhD in Plastic Surgery at University College London where he investigated a tissue engineering approach to repairing peripheral nerves using artificial biological matrices. He then moved to the Institute of Neurology in London to investigate the mechanisms of disease development in Multiple Sclerosis. He then to the University of Birmingham in 2002 where he investigated the mechanisms behind why central nervous system axons fail to regenerate and developed strategies to combat these complications. He was awarded an RCUK Academic Fellowship in NeuroRegeneration in 2007 to develop his own independently funded research programme on themes such as neuroprotection in the eye and neuro-restoration after spinal cord injury. In 2011 he was promoted to Lecturer, then to Senior Lecturer in 2013 and to Professor in Neuroscience in 2021. He continues to investigate the molecular mechanisms underpinning the failure of central nervous system neurons to regenerate after injury and disease. He currently leads the Neuroscience and Ophthalmology Section, a group of diverse clinicians and scientists interested in all aspects of trauma and disease affecting the eye, brain and spinal cord. He is and Editorial Board Member for Brain Sciences and Trauma Care (both from MDPI).
Dr. Evanthia Bernitsas
Multiple Sclerosis Center, Neurology Department, Wayne State University, Detroit, USA
Session 9. Neurotechnology and Neuroimaging
Dr. Bernitsas is a board-certified neurologist and a Multiple Sclerosis expert. After graduating from Aristotle Medical School, Thessaloniki, Greece, she completed a residency at the Case Western Reserve Medical School/University Hospitals in Cleveland and a Neuroimmunology Fellowship at Baylor College of Medicine and University of Michigan Medical Center. Currently, she is the Director of the Multiple Sclerosis/Neuroimmunology Center at Wayne State School of Medicine, Detroit and an Associate Professor of Neurology. Dr. Bernitsas has leaded a high number of clinical trials and investigator-initiated studies, published extensively, and participated in several advisory boards and steering committees.
Sessions
2. Molecular and Cellular Neuroscience
3. Developmental Neuroscience
4. Neuropsychology
5. Systems Neuroscience
6. Sensory and Motor Neuroscience
7. Computational Neuroscience and Neuroinformatics
8. Neurorehabilitation
9. Neurotechnology and Neuroimaging
10. Poster Session
Instructions for Authors
The registration for this conference is FREE and the works selected for their presentation on the conference will be published as conference proceedings with no cost.
- Scholars interested in participating within the conference can submit their abstract online on this website until 25 July 2022. The abstract submitted should be about 200-word in English - the word limits are minimum 150 words and maximum 250 words.
- The Conference Committee will evaluate the abstracts received and decide whether the contribution from the authors of the abstract will be welcome for conference. All the authors will be notified about the acceptance of their works by 5 August 2022.
- If the abstract is accepted for this conference, the authors will be asked to submit an extended manuscript (download the word template here and latex template here) optionally along with a poster and/or PowerPoint presentation of his/her paper (only PDF), up to the full manuscript submission deadline of 5 September 2022.
- The conference proceedings papers and presentations will be available at https://sciforum.net/event/IECBS2022 for discussion during the time of the conference, 01–15 October 2022, and will be published in Journal Biology and Life Sciences Forum.
Manuscripts for the proceedings issue must have the following organization:
First page:
- Title
- Full author names
- Affiliations (including full postal address) and authors' e-mail addresses (institutional addresses preferred)
- Abstract (200–250 words)
- Keywords
Sections:
- Introduction
- Methods
- Results and Discussion
- Conclusions
- (Acknowledgements)
- References
Manuscript Preparation
- Paper Format: A4 paper format, the printing area is 17.5 cm × 26.2 cm. The margins should be 1.75 cm on each side of the paper (top, bottom, left, and right sides).
- Paper Length: The conference proceedings paper should not be longer than 6 pages. The conference manuscript should be as concise as possible.
- Formatting/Style: The paper style of the journal Proceedings should be followed. You may download the template file to prepare your paper (see above). The full titles of the cited papers must be given. Reference numbers should be placed in square brackets [ ], and placed before punctuation; for example [4] or [1–3], and all the references should be listed separately and as the last section at the end of the manuscript.
- Authors List and Affiliation Format: Authors’ full first and last names must be given. Abbreviated middle name(s) can be added. For papers written by various contributors, a corresponding author must be designated. The PubMed/MEDLINE format is used for affiliations: complete street address information including city, zip code, state/province, country, and email address should be added. All authors who contributed significantly to the manuscript (including writing a section) should be listed on the first page of the manuscript, below the title of the article. Other parties who provided only minor contributions should only be listed under Acknowledgments. A minor contribution might be a discussion with the author, reading through the draft of the manuscript, or performing English corrections.
- Figures, Schemes, and Tables: Authors are encouraged to prepare figures and schemes in color. Full color graphics will be published free of charge. Figure and schemes must be numbered (Figure 1, Scheme I, Figure 2, Scheme II, etc.) and an explanatory title must be added. Tables should be inserted into the main text, and numbers and titles for all tables supplied. All table columns should have an explanatory heading. Please supply legends for all figures, schemes, and tables. The legends should be prepared as a separate paragraph of the main text and placed in the main text before a table, figure, or scheme.
Submission of Manuscripts
Presentation Poster or Slides
Posters should have the following information.
- Title (with authors and affiliations)
- Introduction / Objectives / Aims
- Methods
- Results
- Conclusions
- References
- Acknowledgements
- Contact information
Potential Conflicts of Interest
It is the authors' responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state here "The authors declare no conflict of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Financial support for the study must be fully disclosed under "Acknowledgments" section.
Copyright
MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe that authors should retain the copyright to their scholarly works. Hence, by submitting a Conference paper to this conference, you retain the copyright of your paper, but you grant MDPI the non-exclusive right to publish this paper online on the Sciforum.net platform. This means you can easily submit your paper to any scientific journal at a later stage and transfer the copyright to its publisher (if required by that publisher).
Special Issue
"Selected Papers from the 3rd International Electronic Conference on Brain Sciences"
Event Awards
To acknowledge the support of the conference esteemed authors and recognize their outstanding scientific accomplishments, we are pleased to launch the following awards:
The Awards
Number of Awards Available: 1
The Best Paper Award is given to the paper judged to make the most significant contribution to the conference. There will be one winner selected for this award. The winner will receive a certificate, 300 CHF and an opportunity to publish a paper in Brain Sciences with a voucher of 1000 CHF before 1 June 2023.Number of Awards Available: 1
The Best Poster Award is given to the submission judged to make the most significant and interesting poster for the conference. There will be one winner selected for this award. The winner will receive a certificate, 300CHF and an opportunity to publish a paper in Brain Sciences with a voucher of 1000 CHF before 1 June 2023.Terms and Conditions:
1. Full paper/poster must be submitted to IECBS 2022.
2. The quality of the paper/poster.
3. The scientific content of the paper/poster.
Evaluation
1. Each Evaluation Committee member will give an assessment for each paper/poster in terms of the criteria outlined above.
2. The score for each paper/poster will be ranked, from highest to lowest.
3. If two or more papers/posters get the same score, further evaluation will be carried out.
4. All decisions made by the Evaluation Committee are final.
Conference Secretariat
Ms. Bonnie Wu
Ms. Gem Yao
MDPI Branch Office, Beijing
Email: iecbs2022@mdpi.com
For information regarding submission inquiry and sponsoring opportunities, please feel free to contact us.
2. Molecular and Cellular Neuroscience
Show all accepted abstracts (1) Hide accepted abstracts (1)
List of Accepted Abstracts (1) Toggle list
4. Neuropsychology
Session Chair
Prof. Dr. Pierluigi Zoccolotti, Department of Psychology, Sapienza University of Rome, 00185 Rome, Italy, Neuropsychology Unit, IRCCS Fondazione Santa Lucia, 00179 Rome, Italy
5. Systems Neuroscience
Session Chair
Prof. Dr. Konstantin V. Slavin, Department of Neurosurgery, University of Illinois at Chicago, Chicago, USA
7. Computational Neuroscience and Neuroinformatics
8. Neurorehabilitation
Session Chair
Prof. Dr. Zubair Ahmed, Neuroscience and Ophthalmology, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
Show all published submissions (1) Hide published submissions (1)
Submissions
List of Papers (1) Toggle list
9. Neurotechnology and Neuroimaging
Session Chair
Dr. Evanthia Bernitsas, Multiple Sclerosis Center, Neurology Department, Wayne State University, Detroit, USA
Show all published submissions (1) Hide published submissions (1)
Submissions
List of Papers (1) Toggle list
10. Poster Session
Show all published submissions (6) Hide published submissions (6)
Submissions
List of Papers (6) Toggle list